Selected research
Industry Research
Cell Immortalization Industry Research Report 2026
Market perspective
The global Cell Immortalization market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Immortalization market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Immortalization market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Immortalization market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Immortalization include Lonza, Thermo Fisher Scientific, JSR, Sartorius, Merck, AcceGen, Creative Biolabs, InSCREENex GmbH and BioIVT, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Immortalization market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Immortalization.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Immortalization Market by Company
Lonza
Thermo Fisher Scientific
JSR
Sartorius
Merck
AcceGen
Creative Biolabs
InSCREENex GmbH
BioIVT
Krishgen Biosystems
Applied Biological Materials
REPROCELL Inc
FUJIFILM Wako Pure Chemical Corporation
Abace Biotechnology
CELLCOOK
Procell
Takara Bio
Corning
Evercyte
Cell Immortalization Segment by Type
Stem Cell Therapy
Cell Transplantation
Drug Transport
Others
Cell Immortalization Segment by Application
Pharmaceutical and Biopharmaceutical Company
Research Laboratory
Hospital
Other
Cell Immortalization Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Immortalization market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Immortalization and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Immortalization.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Immortalization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Therapy
- Cell Transplantation
- Drug Transport
- Others
Applications
- Pharmaceutical and Biopharmaceutical Company
- Research Laboratory
- Hospital
- Other
Companies covered
- Lonza
- Thermo Fisher Scientific
- JSR
- Sartorius
- Merck
- AcceGen
- Creative Biolabs
- InSCREENex GmbH
- BioIVT
- Krishgen Biosystems
- Applied Biological Materials
- REPROCELL Inc
- FUJIFILM Wako Pure Chemical Corporation
- Abace Biotechnology
- CELLCOOK
- Procell
- Takara Bio
- Corning
- Evercyte
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Immortalization by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stem Cell Therapy
- 2.2.3 Cell Transplantation
- 2.2.4 Drug Transport
- 2.2.5 Others
- 2.3 Cell Immortalization by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biopharmaceutical Company
- 2.3.3 Research Laboratory
- 2.3.4 Hospital
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Cell Immortalization Breakdown Data by Type
- 3.1 Global Cell Immortalization Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Immortalization Forecasted Market Size by Type (2027-2032)
4 Cell Immortalization Breakdown Data by Application
- 4.1 Global Cell Immortalization Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Immortalization Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Immortalization Market Perspective (2021-2032)
- 5.2 Global Cell Immortalization Growth Trends by Region
- 5.2.1 Global Cell Immortalization Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Immortalization Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Immortalization Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Immortalization Market Dynamics
- 5.3.1 Cell Immortalization Industry Trends
- 5.3.2 Cell Immortalization Market Drivers
- 5.3.3 Cell Immortalization Market Challenges
- 5.3.4 Cell Immortalization Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Immortalization Players by Revenue
- 6.1.1 Global Top Cell Immortalization Players by Revenue (2021-2026)
- 6.1.2 Global Cell Immortalization Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Immortalization Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Immortalization Head Office and Area Served
- 6.4 Global Cell Immortalization Players, Product Type & Application
- 6.5 Global Cell Immortalization Manufacturers Established Date
- 6.6 Global Cell Immortalization Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Immortalization Market Size (2021-2032)
- 7.2 North America Cell Immortalization Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Immortalization Market Size by Country (2021-2026)
- 7.4 North America Cell Immortalization Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Immortalization Market Size (2021-2032)
- 8.2 Europe Cell Immortalization Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Immortalization Market Size by Country (2021-2026)
- 8.4 Europe Cell Immortalization Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Immortalization Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Immortalization Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Immortalization Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Immortalization Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Immortalization Market Size (2021-2032)
- 10.2 South America Cell Immortalization Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Immortalization Market Size by Country (2021-2026)
- 10.4 South America Cell Immortalization Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Immortalization Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Immortalization Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Immortalization Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Immortalization Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Lonza
- 12.1.1 Lonza Company Information
- 12.1.2 Lonza Business Overview
- 12.1.3 Lonza Revenue in Cell Immortalization Business (2021-2026)
- 12.1.4 Lonza Cell Immortalization Product Portfolio
- 12.1.5 Lonza Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Cell Immortalization Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Cell Immortalization Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 JSR
- 12.3.1 JSR Company Information
- 12.3.2 JSR Business Overview
- 12.3.3 JSR Revenue in Cell Immortalization Business (2021-2026)
- 12.3.4 JSR Cell Immortalization Product Portfolio
- 12.3.5 JSR Recent Developments
- 12.4 Sartorius
- 12.4.1 Sartorius Company Information
- 12.4.2 Sartorius Business Overview
- 12.4.3 Sartorius Revenue in Cell Immortalization Business (2021-2026)
- 12.4.4 Sartorius Cell Immortalization Product Portfolio
- 12.4.5 Sartorius Recent Developments
- 12.5 Merck
- 12.5.1 Merck Company Information
- 12.5.2 Merck Business Overview
- 12.5.3 Merck Revenue in Cell Immortalization Business (2021-2026)
- 12.5.4 Merck Cell Immortalization Product Portfolio
- 12.5.5 Merck Recent Developments
- 12.6 AcceGen
- 12.6.1 AcceGen Company Information
- 12.6.2 AcceGen Business Overview
- 12.6.3 AcceGen Revenue in Cell Immortalization Business (2021-2026)
- 12.6.4 AcceGen Cell Immortalization Product Portfolio
- 12.6.5 AcceGen Recent Developments
- 12.7 Creative Biolabs
- 12.7.1 Creative Biolabs Company Information
- 12.7.2 Creative Biolabs Business Overview
- 12.7.3 Creative Biolabs Revenue in Cell Immortalization Business (2021-2026)
- 12.7.4 Creative Biolabs Cell Immortalization Product Portfolio
- 12.7.5 Creative Biolabs Recent Developments
- 12.8 InSCREENex GmbH
- 12.8.1 InSCREENex GmbH Company Information
- 12.8.2 InSCREENex GmbH Business Overview
- 12.8.3 InSCREENex GmbH Revenue in Cell Immortalization Business (2021-2026)
- 12.8.4 InSCREENex GmbH Cell Immortalization Product Portfolio
- 12.8.5 InSCREENex GmbH Recent Developments
- 12.9 BioIVT
- 12.9.1 BioIVT Company Information
- 12.9.2 BioIVT Business Overview
- 12.9.3 BioIVT Revenue in Cell Immortalization Business (2021-2026)
- 12.9.4 BioIVT Cell Immortalization Product Portfolio
- 12.9.5 BioIVT Recent Developments
- 12.10 Krishgen Biosystems
- 12.10.1 Krishgen Biosystems Company Information
- 12.10.2 Krishgen Biosystems Business Overview
- 12.10.3 Krishgen Biosystems Revenue in Cell Immortalization Business (2021-2026)
- 12.10.4 Krishgen Biosystems Cell Immortalization Product Portfolio
- 12.10.5 Krishgen Biosystems Recent Developments
- 12.11 Applied Biological Materials
- 12.11.1 Applied Biological Materials Company Information
- 12.11.2 Applied Biological Materials Business Overview
- 12.11.3 Applied Biological Materials Revenue in Cell Immortalization Business (2021-2026)
- 12.11.4 Applied Biological Materials Cell Immortalization Product Portfolio
- 12.11.5 Applied Biological Materials Recent Developments
- 12.12 REPROCELL Inc
- 12.12.1 REPROCELL Inc Company Information
- 12.12.2 REPROCELL Inc Business Overview
- 12.12.3 REPROCELL Inc Revenue in Cell Immortalization Business (2021-2026)
- 12.12.4 REPROCELL Inc Cell Immortalization Product Portfolio
- 12.12.5 REPROCELL Inc Recent Developments
- 12.13 FUJIFILM Wako Pure Chemical Corporation
- 12.13.1 FUJIFILM Wako Pure Chemical Corporation Company Information
- 12.13.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
- 12.13.3 FUJIFILM Wako Pure Chemical Corporation Revenue in Cell Immortalization Business (2021-2026)
- 12.13.4 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Product Portfolio
- 12.13.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
- 12.14 Abace Biotechnology
- 12.14.1 Abace Biotechnology Company Information
- 12.14.2 Abace Biotechnology Business Overview
- 12.14.3 Abace Biotechnology Revenue in Cell Immortalization Business (2021-2026)
- 12.14.4 Abace Biotechnology Cell Immortalization Product Portfolio
- 12.14.5 Abace Biotechnology Recent Developments
- 12.15 CELLCOOK
- 12.15.1 CELLCOOK Company Information
- 12.15.2 CELLCOOK Business Overview
- 12.15.3 CELLCOOK Revenue in Cell Immortalization Business (2021-2026)
- 12.15.4 CELLCOOK Cell Immortalization Product Portfolio
- 12.15.5 CELLCOOK Recent Developments
- 12.16 Procell
- 12.16.1 Procell Company Information
- 12.16.2 Procell Business Overview
- 12.16.3 Procell Revenue in Cell Immortalization Business (2021-2026)
- 12.16.4 Procell Cell Immortalization Product Portfolio
- 12.16.5 Procell Recent Developments
- 12.17 Takara Bio
- 12.17.1 Takara Bio Company Information
- 12.17.2 Takara Bio Business Overview
- 12.17.3 Takara Bio Revenue in Cell Immortalization Business (2021-2026)
- 12.17.4 Takara Bio Cell Immortalization Product Portfolio
- 12.17.5 Takara Bio Recent Developments
- 12.18 Corning
- 12.18.1 Corning Company Information
- 12.18.2 Corning Business Overview
- 12.18.3 Corning Revenue in Cell Immortalization Business (2021-2026)
- 12.18.4 Corning Cell Immortalization Product Portfolio
- 12.18.5 Corning Recent Developments
- 12.19 Evercyte
- 12.19.1 Evercyte Company Information
- 12.19.2 Evercyte Business Overview
- 12.19.3 Evercyte Revenue in Cell Immortalization Business (2021-2026)
- 12.19.4 Evercyte Cell Immortalization Product Portfolio
- 12.19.5 Evercyte Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst